Quinoline-piperazine molecular hybrids as potential antimalarial agents

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Malaria remains a major global health threat, particularly in endemic regions.
• Emerging Plasmodium resistance to current antimalarials necessitates novel drug development.
• Quinoline derivatives are effective antimalarials by inhibiting heme detoxification.

Purpose of the Study:

• To review recent advancements in quinoline-piperazine hybrids for antimalarial drug development.
• To highlight their efficacy against drug-sensitive and drug-resistant Plasmodium falciparum.
• To discuss structure-activity relationships for optimizing antimalarial agents.

Main Methods:

• Literature review of recent studies on quinoline-piperazine hybrids.
• Analysis of reported antimalarial activity against Plasmodium falciparum strains.
• Examination of structure-activity relationship (SAR) data.

Main Results:

• Quinoline-piperazine hybrids demonstrate significant antimalarial activity.
• These hybrids show efficacy against chloroquine-sensitive and resistant Plasmodium strains.
• Piperazine incorporation enhances pharmacokinetic properties and target interactions.

Conclusions:

• Quinoline-piperazine hybrids are promising candidates for next-generation antimalarials.
• Understanding SAR trends aids in designing more potent and selective drugs.
• Further development of these hybrids could overcome existing drug resistance.